Corporate Science meetings & conferences

Molecular Pharming - Recent Progress in Manufacturing Medicines in Plants

Friday, 21 September 2012 09:00 - 17:00 London, United Kingdom

Molecular Pharming is on the brink of taking off! After two decades of development and academic proofs of principle, a number of recent advances have moved the technology rapidly towards commercialisation. The first products are now being licensed in the USA. The first-in-human clinical trial of a plant derived monoclonal antibody has been performed in Europe. And there has been significant investment into manufacturing facilities around the world.

This meeting will review the progress of the field, highlight major technological advances and scan the horizon for future developments.

Contact Details

Email: enquiries@euroscicon.com

Web: www.euroscicon.com

For all accommodation and travel enquiries please contact accommodationandtravel@euroscicon.com

3rd Annual International Conference on Advances in Biotechnology (BioTech 2013)

18 - 19 March 2013 Singapore

Biotechnology is a field of applied biology that involves the use of living organisms and bioprocesses in engineering, technology, medicine and other fields requiring bioproducts. The concept encompasses a wide range of procedures for modifying living organisms according to human purposes - going back to domestication of animals, cultivation of plants, and "improvements" to these through breeding programs that employ artificial selection and hybridization.

This multi-disciplinary conference aims to provide a challenging forum and vibrant opportunity for researchers and industry practitioners to share their original research results and practical development experiences on specific new challenges and emerging issues.

Topics of interest include, but are not limited to:

Pharmaceutical / Medicine

• Structural Biology
• Proteomics
• Cell Cycle and Oncology
• Medical Microbiology
• Diagnostic Pathology
• Clinical Chemistry
• Haematology
• Diagnostic Imaging
• Medical Imaging and Methods
• Sonography
• Molecular and Cell Biology
• Biochemistry
• Immunology
• Genetics
• Neurobiology
• Drug production
• Pharmacogenomics
• Gene therapy
• Factors for transcribing DNA into RNA
• Monoclonol antibodies
• Pathogenesis of Human Diseases
• Presymptomatic testing

Food and Agriculture

• Genetic engineering
• Genomics
• Tissue culture
• Cell fusion
• Molecular biology
• Enzymology
• Fermentation processes
• Instrumentation and diagnostic methods
• Food processing
• Biofertilizer
• Waste Technology
• Environment Control
• Pest and diseases resistant crop
• High value addictives and chemical products
• Immunological techniques
• Signal transduction
• Conjugation
• Classical mutagenesis
• Conjugation process
• Hybridisation

CONFERENCE SECRETARIAT

Global Science & Technology Forum (GSTF)
10 Anson Road, International Plaza,
Singapore 079903
DID : +65 6327 0166
Fax : +65 6327 0162

For Conference Information info@advbiotech.org
For Registration, Accommodation or Visa Assistance secretariat@advbiotech.org

Bioplasma World Asia 2012

July 18-19, 2012 Hong Kong

Bioplasma World Asia 2012 provides Asia’s ONLY Bioplasma and blood products focused conference that brings together regional and international fractionators, regulators and technology specialists to discuss strategies and best practices.

Bioplasma World Asia 2012 brings to you:

-The most targeted platform to meet Asian and international plasma fractionators

-Case studies and discussions from senior level decision makers who will influence the direction of fractionation industry

-Both strategic and technological developments in the fractionation industry.

Asia’s plasma products market update

Asia’s regulatory and quality trends and challenges

-Manufacturing and operational excellence.

-Pathogenic quality control

-Clinical developments and applications

-Innovation and advances in plasma processing

-New product show case

IMAPAC PTE. LTD.

298 Tiong Bahru Road,
#20-04 Central Plaza,
Singapore 168730

Tel: +65 6493 2093
Fax: +65 6270 2792

Email: info@imapac.com

7th Global Forum on Pharmaceutical Anti-Counterfeiting and Diversion

November 27-29, 2012 Washington, DC

Since 2002 Reconnaissance International’s Global Forum on Pharmaceutical Anti-Counterfeiting has brought together the most eclectic mix of stakeholders and leaders who care about safe access to pharmaceuticals. All the previous Global Forums have covered new ground in the discussion of how to best combat counterfeit pharmaceuticals and medical devices. This has stimulated new ideas, encouraged cooperation and catalysed numerous new projects on global, national and company levels.

In the past few years illicit pharmaceutical diversion - a topic covered by the Global Forum - has been growing at an alarming rate. This includes the diversion of shipments from low-price markets to high-price markets and the misuse of prescription medicines. Prescription drug abuse, especially of opiates, is now a major issue, particularly in the USA. The title of the Global Forum has therefore changed with the addition of “Diversion” to recognise the importance of this issue and the need to combat it.

Reconnaissance International
General Enquiries

4 Windmill Business Village
Brooklands Close
Sunbury-on-Thames
Surrey
TW16 7DY
United Kingdom

info@reconnaissance-intl.com
Phone: +44 (0)1932 785 680
Fax: +44 (0)1932 780 790
http://www.reconnaissance-intl.com

IEEE-EMBS Micro- and Nanoengineering in Medicine Conference (MNMC 2012)

Translating Technology from the Bench to the Bedside

December 3-7, 2012 The Westin Maui Resort and Spa, Ka’anapali, Hawaii

Various biomedical grand challenges facing our society and the world can be addressed by interfacing biology and medicine with micro- and nanoscale technologies. These technologies hold great potential to impact early diagnosis, therapeutics, and management of disease. IEEE EMBS is sponsoring the first Conference on Micro- and Nanoengineering in Medicine to foster interaction between scientists, engineers and medical researchers in the context of real-world medical needs and issues. The Conference will promote vigorous and open dialogue towards the development of cutting edge technologies for faster, more quantitative, and less expensive biomedical solutions using advances in micro and nanotechnology.

3rd AMA-IEEE Medical Technology Conference: Translational Engineering in Health & Medicine: the Intersection of the Lab, the Clinic and the Community

The American Medical Association (AMA) and the IEEE Engineering in Medicine and Biology (EMB) Society are pleased to announce the 3rd AMA-IEEE Medical Technology Conference: Translational Engineering in Health & Medicine: the intersection of the lab, the clinic and the community in Houston, TX, on 7th-9th November 2012 at the Methodist Hospital Research Institute in the Texas Medical Center.

This conference is devoted to the exploration of the intersection of engineering, medicine, and health. Emphasis will be placed on novel innovations that have a foreseeable impact on human health and disease. Specific areas of interest include Imaging; Nano Medicine; Data Mining and the Use of Large Datasets; Remote Sensing; Networks & Communication; Applied Metabolomics; Aerospace and Harsh Environments; and Global Health.

We invite participation by physicians, nurses and other healthcare professionals, engineers, innovators, entrepreneurs, industrial leaders, government agencies and policy makers. The conference will be inaugurated by a keynote lecture and evening reception on Wednesday, 7th November. The following two days will feature plenary, break-out sessions and poster presentations focusing on Translational Engineering in Health & Medicine.

Polymer Chemistry Conference 2012

Polymers: From Biomedical Applications to Energy

Monday November 12 2012 - Friday November 16 2012 Xcaret, Mexico

The continued application of synthetic chemistry to the development of new polymer-based materials has given polymer chemistry a critical role in the development of new materials across a broad range of applications that impact our lives, most recently in biomedical and energy-related areas. Synthetic methodologies that allow the shaping of polymeric materials to function as biomaterials in applications including tissue engineering, imaging, and the targeted delivery of drugs and biological materials will be presented. We will showcase creative designs and synthetic strategies for these multifunctional polymeric systems and composite materials. The multifaceted properties of polymers allow for the increasing advancement of polymers in energy-related applications. The optimization of polymer-based organic photovoltaic and hybrid materials for harvesting and storing solar energy, as well as the development of new semiconducting polymers will be topics of particular interest. The unique site and forum will give the attendees many opportunities to exchange ideas, discuss research challenges and forge new collaborations. The total number of attendees will be kept to a maximum of 100 to facilitate such interactions. The themes in 2012 will include: - Synthesis of Biomaterials - Applications of Nanomaterials in Medicine - Self assembly - Theranostics - Polymer Surfaces - Polymers for Imaging and Devices - Polymers and Energy

Contact us
For general queries about conference attendance, registration, payment, accommodation, etc. please email info~at~zingconferences.com (replace '~at~' with '@').

Peptide Chemistry Conference 2012

Friday November 2 2012 - Tuesday November 6 2012 Xcaret, Mexico

The interest of pharmaceutical companies for peptides is increasing enormously in the last decade. There are several reasons for that. In first place, the number of the so-called small molecules accepted for the corresponding agencies are declining. In this sense, pharmaceutical are looking more to biological based drugs. Furthermore, the advances in fields of formulation, drug delivery technology and chemical modifications, have rekindled the interest in peptides as APIs.

This would not be possible without the concurrence of strong peptide chemistry. The development of new resins for the solid-phase methodology, coupling reagents, orthogonal protecting groups, and synthetic strategies are being allowed the rapid and efficient synthesis of small and large peptides for research and, then, the multi-ton preparation of the API based peptides.

This Zing conference will be totally devoted into the latest developments in peptide chemistry. In addition to the parameters outlined above, the following topics will be discussed:

Synthesis of building blocks
use of microwave and other technologies
syntheses of foldamers, peptide conjugates, and peptides for nanotechnologies
preparation of peptide libraries
chemical ligation for protein synthesis
syntheses of complex cyclic peptide of natural origin and peptide mimetics
industrial synthesis of peptides

Attendees from the academia and the industry as well Ph.D. students and post-doctoral fellows will fulfill an unique atmosphere around the peptide world.

Contact us
For general queries about conference attendance, registration, payment, accommodation, etc. please email info~at~zingconferences.com (replace '~at~' with '@').
 

3rd Annual Modern Challenges in Therapeutic Protein Production Event

Thursday, 14 June 2012 London, United Kingdom 

The purpose of this annual event is to look at the challenges facing therapeutic protein production and demystify some of the novel approaches and new technologies currently being developed.

Contact Details
Email: enquiries@euroscicon.com

Web: www.lifescienceevents.com

For all accommodation and travel enquiries please contact accommodationandtravel@euroscicon.com

4th Annual Personalized Medicine Conference

September 12-13, 2012 Boston, Massachusetts

Personalized medicine has the potential to revolutionize medical care by utilizing an improved understanding of genetics and molecular biology to allow for better diagnostic tests, more precise diagnoses, greater predictability of disease course, and improved patient safety by selecting not only the right drug for a patient but also the proper dosage to reduce adverse effects. Speakers and panelists will answer the following key questions:

What types of challenges need to be met in order to realize the true commercial potential of personalized medicine?
Will insurers fund the genomic revolution?
What types of validation requirements are they looking for?
What will be their criteria for reimbursement?
What are the real-world challenges to successful adoption of molecular/companion diagnostics?
Who needs to partner in order to advance the field of personalized medicine?
What are the goals, utility and challenges associated with Rx-Dx partnerships?
How and when are relationships being initiated today?
How are companies navigating their way through the world's regulatory bodies?
What kind of impact are Pharmacy Benefit Managers (PBMs) and for that matter new genetic testing benefit managers going to have on the future of personalized medicine?
What types of efforts are being made to influence adoption via physician education?

Arrowhead Publishers and Conferences
5412 Irving Avenue South
Minneapolis
MN
55419
USA

E-mail: enquiries@personalizedmedicinepartnerships.com
Telephone: 312-244-3703
Fax: 312-244-3703
http://www.arrowheadpublishers.com